Chancey Jessica Hotard, Shockett Penny E, O'Reilly John P
Department of Biological Sciences, Southeastern Louisiana University, Hammond, LA 70402, USA.
Am J Physiol Cell Physiol. 2007 Dec;293(6):C1895-905. doi: 10.1152/ajpcell.00377.2007. Epub 2007 Oct 10.
Transmembrane segment 6 is implicated in slow inactivation (SI) of voltage-gated Na(+) channels (Na(v)s). To further study its role and understand differences between SI phenotypes of different Na(v) isoforms, we analyzed several domain 2-segment 6 (D2-S6) mutants of the human cardiac hNa(v)1.5, which is relatively resistant to SI. Mutants were examined by transient HEK cell transfection and patch-clamp recording of whole cell Na(+) currents. Substitutions with lysine (K) included N927K, V930K, and L931K. We show recovery from short (100 ms) depolarization to 0 mV in N927K and L931K is comparable to wild type, whereas recovery in V930K is delayed and biexponential, suggesting rapid entry into a slow-inactivated state. SI protocols confirm enhanced SI phenotype (rapid development, hyperpolarized steady state, slowed recovery) for V930K, contrasting with the resistant phenotype of wild-type hNa(v)1.5. This enhancement, not found in N927K or L931K, suggests that the effect in V930K is site specific. Glutamine (Q) substituted at V930 also exhibits an enhanced SI phenotype similar to that of V930K. Therefore, K or Q substitution eliminates hNa(v)1.5 resistance to SI. Alanine (A) or cysteine (C) substitution at V930 shows no enhancement of SI, and in fact, V930A and V930C, as well as L931K, exhibit a resistance to SI, demonstrating that characteristics of specific amino acids (e.g., size, hydrophobicity) differentially affect SI gating. Thus V930 in D2-S6 appears to be an important structural determinant of SI gating in hNa(v)1.5. We suggest that conformational change involving D2-S6 is a critical component of SI in Na(v)s, which may be differentially regulated between isoforms by other isoform-specific determinants of SI phenotype.
跨膜片段6与电压门控钠通道(Na(v)s)的慢失活(SI)有关。为了进一步研究其作用并了解不同Na(v)亚型SI表型之间的差异,我们分析了人类心脏hNa(v)1.5的几个结构域2 - 片段6(D2 - S6)突变体,该亚型对SI相对具有抗性。通过瞬时转染HEK细胞并对全细胞钠电流进行膜片钳记录来检测突变体。用赖氨酸(K)进行的替换包括N927K、V930K和L931K。我们发现,N927K和L931K从短(100毫秒)去极化恢复到0 mV的情况与野生型相当,而V930K的恢复延迟且呈双指数形式,表明其快速进入慢失活状态。SI实验方案证实了V930K具有增强的SI表型(快速发展、超极化稳态、恢复缓慢),这与野生型hNa(v)1.5的抗性表型形成对比。在N927K或L931K中未发现这种增强现象,这表明V930K中的效应是位点特异性的。在V930处用谷氨酰胺(Q)替换也表现出与V930K相似的增强的SI表型。因此,用K或Q替换消除了hNa(v)1.5对SI的抗性。在V930处用丙氨酸(A)或半胱氨酸(C)替换未显示SI增强,实际上,V930A和V930C以及L931K都表现出对SI的抗性,这表明特定氨基酸的特性(如大小、疏水性)对SI门控有不同影响。因此,D2 - S6中的V930似乎是hNa(v)1.5中SI门控的重要结构决定因素。我们认为,涉及D2 - S6的构象变化是Na(v)s中SI的关键组成部分,不同亚型之间可能由其他SI表型的亚型特异性决定因素进行差异调节。